Ligand Pharmaceuticals Incorporated (LGND): Price and Financial Metrics

LGND POWR Grades

• Sentiment is the dimension where LGND ranks best; there it ranks ahead of 65.16% of US stocks.
• The strongest trend for LGND is in Growth, which has been heading down over the past 179 days.
• LGND ranks lowest in Stability; there it ranks in the 18th percentile.

LGND Stock Summary

• With a year-over-year growth in debt of -25.88%, Ligand Pharmaceuticals Inc's debt growth rate surpasses only 15.88% of about US stocks.
• Over the past twelve months, LGND has reported earnings growth of 296.42%, putting it ahead of 92.84% of US stocks in our set.
• As for revenue growth, note that LGND's revenue has grown 48.66% over the past 12 months; that beats the revenue growth of 80.91% of US companies in our set.
• If you're looking for stocks that are quantitatively similar to Ligand Pharmaceuticals Inc, a group of peers worth examining would be WATT, SITM, PI, MPWR, and PACB.
• Visit LGND's SEC page to see the company's official filings. To visit the company's web site, go to www.ligand.com.

LGND Valuation Summary

• LGND's EV/EBIT ratio is 46.3; this is 58.02% higher than that of the median Healthcare stock.
• Over the past 243 months, LGND's price/sales ratio has gone down 0.9.
• Over the past 243 months, LGND's price/sales ratio has gone down 0.9.

Below are key valuation metrics over time for LGND.

LGND Growth Metrics

Its 3 year net income to common stockholders growth rate is now at 190.46%.
• Its 2 year revenue growth rate is now at -34.54%.
• Its 3 year net cashflow from operations growth rate is now at 277.8%.

LGND's revenue has moved up $148,310,000 over the prior 52 months.

The table below shows LGND's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	277.133	78.798	57.138
2021-09-30	274.65	51.693	68.315
2021-06-30	251.663	44.413	47.891
2021-03-31	208.408	48.418	39.252
2020-12-31	186.419	54.586	-2.985
2020-09-30	143.432	46.71	-16.111

LGND's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• LGND has a Quality Grade of C, ranking ahead of 59.87% of graded US stocks.
• LGND's asset turnover comes in at 0.195 -- ranking 202nd of 681 Pharmaceutical Products stocks.
• NBIX, IRWD, and MNKD are the stocks whose asset turnover ratios are most correlated with LGND.

The table below shows LGND's key quality metrics over time.